Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction

Cell Reports

Volumn 5, Issue 4, 2013, Pages 895-908

  Lin, Tsai Yu ^a   Chin, Christopher R ^a,b   Everitt, Aaron R ^c   Clare, Simon ^c   Perreira, Jill M ^a   Savidis, George ^a   Aker, Aaron M ^a   John, Sinu P ^b   Sarlah, David ^d   Carreira, Erick M ^d   Elledge, Stephen J ^e,f,g   Kellam, Paul ^c,h   Brass, Abraham L ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ETH ZURICH   (Switzerland)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; IFITM3 PROTEIN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUSION; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA A; INFLUENZA VIRUS A; LUNG EDEMA; LUNG HEMORRHAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALIA; INFLUENZA A VIRUS;

ACETYLCHOLINE; AMPHOTERICIN B; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIGENS, DIFFERENTIATION; BIOLOGICAL TRANSPORT; CELL FUSION; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; HELA CELLS; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERONS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NYSTATIN; ORTHOMYXOVIRIDAE INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SODIUM; TETRAETHYLAMMONIUM; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84888439736     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.10.033     Document Type: Article

References (45)

1. Abu-Salah K.M. Perturbation of the fluidity of the erythrocyte membrane with ionophoric antibiotics and lipophilic anaesthetics. Biochem. Pharmacol. 1991, 42:1947-1951.
2. Amini-Bavil-Olyaee S., Choi Y.J., Lee J.H., Shi M., Huang I.C., Farzan M., Jung J.U. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013, 13:452-464.
3. Bailey C.C., Huang I.C., Kam C., Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 2012, 8:e1002909.
4. Bellmann R. Clinical pharmacokinetics of systemically administered antimycotics. Curr. Clin. Pharmacol. 2007, 2:37-58.
5. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim. Biophys. Acta 1986, 864:257-304.
6. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
7. Brutyan R.A., McPhie P. On the one-sided action of amphotericin B on lipid bilayer membranes. J.Gen. Physiol. 1996, 107:69-78.
8. Cai C., Zhu H., Chen J. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox. Biochem. Biophys. Res. Commun. 2004, 320:868-874.
9. Callan-Jones A., Bassereau P. Membrane fission: curvature-sensitive proteins cut it both ways. Dev. Cell 2012, 22:691-692.
10. Cybulska B., Bolard J., Seksek O., Czerwinski A., Borowski E. Identification of the structural elements of amphotericin B and other polyene macrolide antibiotics of the hepteane group influencing the ionic selectivity of the permeability pathways formed in the red cell membrane. Biochim. Biophys. Acta 1995, 1240:167-178.
11. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 2013, 13:46-57.
12. Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484:519-523. GenISIS Investigators, MOSAIC InvestigatorsMOSAIC Investigators.
13. Feeley E.M., Sims J.S., John S.P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., Brass A.L. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011, 7:e1002337.
14. Hartsel S.C., Benz S.K., Ayenew W., Bolard J. Na+, K+ and Cl-selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics. Eur. Biophys. J. 1994, 23:125-132.
15. Helenius A., Kielian M., Wellsteed J., Mellman I., Rudnick G. Effects of monovalent cations on Semliki Forest virus entry into BHK-21 cells. J.Biol. Chem. 1985, 260:5691-5697.
16. Henry-Toulmé N., Sarthou P., Seman M., Bolard J. Membrane effects of the polyene antibiotic amphotericin B and of some of its derivatives on lymphocytes. Mol. Cell. Biochem. 1989, 91:39-44.
17. Hoop C.L., Sivanandam V.N., Kodali R., Srnec M.N., van der Wel P.C. Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes. Biochemistry 2012, 51:90-99.
18. Huang I.C., Bailey C.C., Weyer J.L., Radoshitzky S.R., Becker M.M., Chiang J.J., Brass A.L., Ahmed A.A., Chi X., Dong L., et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011, 7:e1001258.
19. Ivanovic T., Choi J.L., Whelan S.P., van Oijen A.M., Harrison S.C. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. eLife 2013, 2:e00333.
20. Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J.Virol. 2010, 84:8332-8341.
21. John S.P., Chin C.R., Perreira J.M., Feeley E.M., Aker A.M., Savidis G., Smith S.E., Elia A.E., Everitt A.R., Vora M., et al. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J.Virol. 2013, 87:7837-7852.
22. Li K., Markosyan R.M., Zheng Y.M., Golfetto O., Bungart B., Li M., Ding S., He Y., Liang C., Lee J.C., et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 2013, 9:e1003124.
23. Medina R.A., García-Sastre A. Influenza A viruses: new research developments. Nat. Rev. Microbiol. 2011, 9:590-603.
24. Moen M.D., Lyseng-Williamson K.A., Scott L.J. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009, 69:361-392.
25. Mudhasani R., Tran J.P., Retterer C., Radoshitzky S.R., Kota K.P., Altamura L.A., Smith J.M., Packard B.Z., Kuhn J.H., Costantino J., et al. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J.Virol. 2013, 87:8451-8464.
26. Nikolaus J., Herrmann A. Functional relevance of transmembrane domains in membrane fusion. Biol. Chem. 2012, 393:1231-1245.
27. Paquet V., Volmer A.A., Carreira E.M. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B. Chemistry 2008, 14:2465-2481.
28. Perreira J.M., Chin C.R., Feeley E.M., Brass A.L. IFITMs restrict the replication of multiple pathogenic viruses. J.Mol. Biol. 2013, Published online September 25, 2013. 10.1016/j.jmb.2013.09.024.
29. Rawat S.S., Zimmerman C., Johnson B.T., Cho E., Lockett S.J., Blumenthal R., Puri A. Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol. Membr. Biol. 2008, 25:83-94.
30. Roethl E., Gassner M., Krenn B.M., Romanovskaya-Romanko E.A., Seper H., Romanova J., Nakowitsch S., Sturlan S., Wolschek M., Sirotkin A., et al. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture. J.Virol. 2011, 85:11139-11145.
31. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of thetype I interferon antiviral response. Nature 2011, 472:481-485.
32. Scott C.C., Gruenberg J. Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. Bioessays 2011, 33:103-110.
33. Terazima E., Yoshino M. Modulatory action of acetylcholine onthe Na+-dependent action potentials in Kenyon cells isolated from the mushroom body of the cricket brain. J.Insect Physiol. 2010, 56:1746-1754.
34. Voeltz G.K., Prinz W.A., Shibata Y., Rist J.M., Rapoport T.A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 2006, 124:573-586.
35. Volmer A.A., Carreira E.M. Active amphotericin B derivatives position the mycosamine in two radial orientations. Chembiochem 2010, 11:778-781.
36. Wakim L.M., Gupta N., Mintern J.D., Villadangos J.A. Enhanced survival of lung tissue-resident memory CD8(+) Tcells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 2013, 14:238-245.
37. Wee Y.S., Roundy K.M., Weis J.J., Weis J.H. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun. 2012, 18:834-845.
38. Weidner J.M., Jiang D., Pan X.B., Chang J., Block T.M., Guo J.T. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J.Virol. 2010, 84:12646-12657.
39. White J., Matlin K., Helenius A. Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J.Cell Biol. 1981, 89:674-679.
40. White J., Helenius A., Gething M.J. Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature 1982, 300:658-659.
41. Wilkins C., Woodward J., Lau D.T., Barnes A., Joyce M., McFarlane N., McKeating J.A., Tyrrell D.L., Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 2013, 57:461-469.
42. Wyles J.P., McMaster C.R., Ridgway N.D. Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum. J.Biol. Chem. 2002, 277:29908-29918.
43. Younsi M., Ramanandraibe E., Bonaly R., Donner M., Coulon J. Amphotericin B resistance and membrane fluidity in Kluyveromyces lactis strains. Antimicrob. Agents Chemother. 2000, 44:1911-1916.
44. Yount J.S., Karssemeijer R.A., Hang H.C. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J.Biol. Chem. 2012, 287:19631-19641.
45. Zhang Y.H., Zhao Y., Li N., Peng Y.-C., Giannoulatou E., Jin R.-H., Yan H.-P., Wu H., Liu J.-H., Liu N., et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat. Commun. 2013, 4:1418.